The Predicted Effects of Chronic Obesity in Middle Age on Medicare Costs and Mortality

National Center for Health Statistics, Centers for Disease Control and Prevention, Eastsound, WA, USA.
Medical care (Impact Factor: 2.94). 06/2010; 48(6):510-7. DOI: 10.1097/MLR.0b013e3181dbdb20
Source: PubMed

ABSTRACT The prevalence of adult obesity has increased in recent decades. It is important to predict the long-term effect of body weight, and changes in body weight, in middle age on longevity and Medicare costs in older ages.
The relationships between individuals' characteristics in middle age and subsequent Medicare costs and mortality were estimated from the linkage of the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study to Medicare administrative records (1991-2000) and mortality information (1971-2000). We predicted longevity and lifetime Medicare costs via simulation for 45-year-old persons by body weight in 1973 and changes in body weight between 1973 and 1983.
Obese 45-year-olds had a smaller chance of surviving to age 65 and, if they did, incurred significantly higher average lifetime Medicare costs than normal-weight 45-year-olds ($163,000 compared with $117,000). Those who remained obese between ages 45 and 55 in 1973 to 1983 incurred significantly higher lifetime Medicare costs than those who maintained normal weight. Other weight change categories did not differ significantly from those who maintained normal weight in terms of life expectancy at age 65, but overweight and obese people who lost weight had less chance of surviving to age 65 and the lowest estimated life expectancies thereafter.
Chronic obesity in middle age increases lifetime Medicare costs relative to those who remained normal weight. As the survival of obese persons improves, it is possible that Medicare costs may rise substantially in the future to meet the health care needs of today's obese middle-aged population. Thus, active engagement by both the private and public sectors to prevent and to reduce obesity are critically needed.

  • [Show abstract] [Hide abstract]
    ABSTRACT: In this paper we examine whether health status and functional capacity explain the fact that obese individuals report significantly lower levels of subjective well-being. We use comprehensive measures of body composition such as waist circumference, body fat percentage, and lean body mass along with body mass index. All these are measured by health professionals in a population-based sample. When controlling for health and functional status, we find very limited evidence for any independent influence of obesity on subjective well-being. This implies that the adverse effects of obesity on health and functioning are the primary explanation for the observed negative relationship between obesity and subjective well-being.
    Journal of Happiness Studies 08/2013; DOI:10.1007/s10902-013-9453-8 · 1.88 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Objective: The objective of this study was to (a) to examine whether the association between obesity and physical functioning among older adults is moderated by physical activity (PA) and (b) to test whether this moderating effect varies by gender. Method: Data from adults (aged >60 years) who participated in the National Health and Nutrition Examination Surveys (2005-2010) were analyzed. Using multivariate logistic regression, we estimated the prevalence ratio (PR) of functional limitations and impairment in activities of daily living and instrumental activities of daily living, by body mass index and PA, while adjusting for age, educational level, and a comorbidity index. Results: The sample included 5,304 subjects (mean age = 70.4 years), and 50.5% were female. Overweight and obesity were associated with higher levels of functional limitations when compared with normal weight individuals regardless of the PA status (PR = 1.47, 95% confidence interval [CI] [1.17, 1.85], and PR = 2.71, 95% CI [2.00, 3.67], respectively) even after adjustment for confounders. Discussion: Overweight and obesity are associated with impairment in functional outcomes irrespective of PA.
    Journal of Aging and Health 06/2014; 26(6). DOI:10.1177/0898264314535635 · 1.56 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Adipose tissue, best known for its role in fat storage, can also suppress weight gain and metabolic disease through the action of specialized, heat-producing adipocytes. Brown adipocytes are located in dedicated depots and express constitutively high levels of thermogenic genes, whereas inducible 'brown-like' adipocytes, also known as beige cells, develop in white fat in response to various activators. The activities of brown and beige fat cells reduce metabolic disease, including obesity, in mice and correlate with leanness in humans. Many genes and pathways that regulate brown and beige adipocyte biology have now been identified, providing a variety of promising therapeutic targets for metabolic disease.
    Nature medicine 10/2013; 19(10):1252-1263. DOI:10.1038/nm.3361 · 28.05 Impact Factor


Available from
Jun 4, 2014